Close

Ratings by Morgan Stanley (Vikram Purohit)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/11/2022 Ascendis Pharma ASND Maintain Overweight
(N/A)
 
 
  Details
8/10/2022 Axsome Therapeutics AXSM Maintain Equalweight
(N/A)
 
 
  Details
8/2/2022 Arcutis Biotherapeutics Inc. ARQT Maintain Overweight
(N/A)
 
 
  Details
7/25/2022 Theravance Biopharma TBPH Maintain Underweight
(N/A)
 
 
  Details
7/8/2022 Axsome Therapeutics AXSM Maintain Equalweight
(N/A)
 
 
  Details
7/5/2022 Talaris Therapeutics TALS Downgrade Equalweight
(Overweight)
4.51
(4.10)
-9.09% Details
6/13/2022 Exscientia PLC EXAI Maintain Equalweight
(N/A)
 
 
  Details
6/3/2022 Instil Bio Inc TIL Maintain Equalweight
(N/A)
 
 
  Details
5/20/2022 Foghorn Therapeutics FHTX Maintain Overweight
(N/A)
 
 
  Details
5/10/2022 Sage Therapeutics SAGE Maintain Equalweight
(N/A)
 
 
  Details
5/6/2022 Axsome Therapeutics AXSM Maintain Equalweight
(N/A)
 
 
  Details
5/6/2022 Certara Inc. CERT Maintain Equalweight
(N/A)
 
 
  Details
5/4/2022 Incyte INCY Maintain Equalweight
(N/A)
 
 
  Details
5/4/2022 Kymera Therapeutics KYMR Maintain Equalweight
(N/A)
 
 
  Details
4/20/2022 Incyte INCY Maintain Equalweight
(N/A)
 
 
  Details
4/11/2022 Exscientia PLC EXAI Maintain Equalweight
(N/A)
 
 
  Details
3/22/2022 Regenxbio Inc. RGNX Maintain Overweight
(N/A)
 
 
  Details
3/22/2022 Talaris Therapeutics TALS Maintain Overweight
(N/A)
 
 
  Details
3/3/2022 Certara Inc. CERT Maintain Equalweight
(N/A)
 
 
  Details
2/9/2022 Incyte INCY Maintain Equalweight
(N/A)
 
 
  Details
1/19/2022 Axsome Therapeutics AXSM Maintain Equalweight
(N/A)
 
 
  Details
12/15/2021 Foghorn Therapeutics FHTX Maintain Overweight
(N/A)
 
 
  Details
12/10/2021 Radius Health RDUS Downgrade Underweight
(Equalweight)
8.01
(10.08)
25.84% Details
11/19/2021 Schrodinger SDGR Downgrade Equalweight
(Overweight)
44.45
(28.00)
-37.01% Details
11/12/2021 HOOKIPA Pharma Inc. HOOK Downgrade Equalweight
(Overweight)
4.35
(1.56)
-64.14% Details
11/11/2021 Certara Inc. CERT Maintain Equalweight
(N/A)
 
 
  Details
11/8/2021 Sage Therapeutics SAGE Maintain Equalweight
(N/A)
 
 
  Details
10/26/2021 Exscientia PLC EXAI New Coverage Equalweight
(N/A)
22.20
(9.73)
-56.17% Details
10/19/2021 Sage Therapeutics SAGE New Coverage Equalweight
(N/A)
44.07
(42.20)
-4.24% Details
10/19/2021 Regenxbio Inc. RGNX New Coverage Overweight
(N/A)
35.38
(31.09)
-12.13% Details
10/19/2021 Kaleido Biosciences Inc. KLDO Downgrade Underweight
(Equalweight)
4.94
(0.29)
-94.13% Details
9/23/2021 Incyte INCY Maintain Equalweight
(N/A)
 
 
  Details
9/16/2021 Theravance Biopharma TBPH Maintain Underweight
(N/A)
 
 
  Details
9/7/2021 Theravance Biopharma TBPH Maintain Underweight
(N/A)
 
 
  Details
8/25/2021 Theravance Biopharma TBPH Downgrade Underweight
(Overweight)
14.17
(9.32)
-34.23% Details
8/18/2021 Kymera Therapeutics KYMR Maintain Equalweight
(N/A)
 
 
  Details
8/18/2021 HOOKIPA Pharma Inc. HOOK Maintain Overweight
(N/A)
 
 
  Details
8/10/2021 Tscan Therapeutics Inc TCRX New Coverage Overweight
(N/A)
10.46
(3.06)
-70.75% Details
8/10/2021 Axsome Therapeutics AXSM Downgrade Equalweight
(Overweight)
51.16
(59.26)
15.83% Details
7/16/2021 Theravance Biopharma TBPH Maintain Overweight
(N/A)
 
 
  Details
7/16/2021 Kymera Therapeutics KYMR Maintain Equalweight
(N/A)
 
 
  Details
6/1/2021 Talaris Therapeutics TALS New Coverage Overweight
(N/A)
15.12
(4.10)
-72.88% Details
5/26/2021 Instil Bio Inc TIL Maintain Equalweight
(Equalweight)
 
 
  Details
5/26/2021 Axsome Therapeutics AXSM Maintain Overweight
(Overweight)
 
 
  Details
5/18/2021 Radius Health RDUS Maintain Equalweight
(Equalweight)
 
 
  Details
5/18/2021 Kymera Therapeutics KYMR Maintain Equalweight
(Equalweight)
 
 
  Details
5/13/2021 Theravance Biopharma TBPH Maintain Overweight
(Overweight)
 
 
  Details
5/4/2021 Incyte INCY Maintain Equalweight
(N/A)
 
 
  Details
4/13/2021 Instil Bio Inc TIL New Coverage Equalweight
(N/A)
22.03
(5.76)
-73.85% Details
4/8/2021 HOOKIPA Pharma Inc. HOOK New Coverage Overweight
(N/A)
13.56
(1.56)
-88.5% Details
4/5/2021 Incyte INCY Maintain Equalweight
(Equalweight)
 
 
  Details
3/22/2021 Kymera Therapeutics KYMR Maintain Equalweight
(Equalweight)
 
 
  Details
3/22/2021 Foghorn Therapeutics FHTX Maintain Overweight
(Overweight)
 
 
  Details
3/8/2021 Certara Inc. CERT Maintain Equalweight
(Equalweight)
 
 
  Details
3/2/2021 Axsome Therapeutics AXSM Maintain Overweight
(Overweight)
 
 
  Details
3/1/2021 Theravance Biopharma TBPH Maintain Overweight
(Overweight)
 
 
  Details
2/25/2021 Pandion Therapeutics PAND Downgrade Equalweight
(Overweight)
25.63
(60.05)
134.3% Details
2/10/2021 Incyte INCY Maintain Equalweight
(Equalweight)
 
 
  Details
1/19/2021 Kymera Therapeutics KYMR Maintain Equalweight
(Equalweight)
 
 
  Details
1/6/2021 Certara Inc. CERT New Coverage Equalweight
(N/A)
33.00
(16.31)
-50.58% Details
11/9/2020 Incyte INCY Maintain Equalweight
(N/A)
 
 
  Details
10/14/2020 Theravance Biopharma TBPH Upgrade Overweight
(Equalweight)
17.62
(14.17)
-19.58% Details
8/25/2020 Radius Health RDUS Maintain Equalweight
(N/A)
 
 
  Details
8/6/2020 Incyte INCY Maintain Equalweight
(N/A)
 
 
  Details
5/13/2020 Radius Health RDUS Downgrade Equalweight
(Overweight)
14.80
(10.08)
-31.89% Details
5/12/2020 Incyte INCY Maintain Equalweight
(N/A)
 
 
  Details
5/8/2020 Portola Pharmaceuticals PTLA Maintain Equalweight
(N/A)
 
 
  Details
4/29/2020 Incyte INCY Downgrade Equalweight
(Overweight)
102.98
(73.78)
-28.36% Details
4/1/2020 Incyte INCY Upgrade Overweight
(Equalweight)
72.17
(73.78)
2.23% Details
3/6/2020 Radius Health RDUS Maintain Overweight
(N/A)
 
 
  Details
3/3/2020 Unum Therapeutics UMRX Downgrade Equalweight
(Overweight)
0.67
(2.35)
250.75% Details
2/28/2020 Portola Pharmaceuticals PTLA Maintain Equalweight
(N/A)
 
 
  Details
1/10/2020 Portola Pharmaceuticals PTLA Maintain Equalweight
(N/A)
 
 
  Details
11/27/2019 Unum Therapeutics UMRX Maintain Overweight
(N/A)
 
 
  Details
11/26/2019 Neon Therapeutics NTGN Downgrade Underweight
(Overweight)
1.35
(3.07)
127.41% Details
11/6/2019 Portola Pharmaceuticals PTLA Maintain Equalweight
(N/A)
 
 
  Details
10/11/2019 Radius Health RDUS Maintain Overweight
(N/A)
 
 
  Details
9/5/2019 Unum Therapeutics UMRX New Coverage Overweight
(N/A)
1.69
(2.35)
39.05% Details
9/5/2019 Radius Health RDUS New Coverage Overweight
(N/A)
27.70
(10.08)
-63.61% Details
9/5/2019 Neon Therapeutics NTGN New Coverage Overweight
(N/A)
2.55
(1.35)
-47.06% Details
9/5/2019 Portola Pharmaceuticals PTLA New Coverage Equalweight
(N/A)
28.40
(18.03)
-36.51% Details
9/5/2019 DBV Technologies S.A DBVT New Coverage Equalweight
(N/A)
9.42
(2.40)
-74.52% Details